Abstract
To the Editor,We are pleased that Rifai et al. share our concerns oncoagulation abnormalities induced by the extracorporealliversupportdevicePrometheus(Fresenius,BadHomburg,Germany) (1). We previously reported on repeated occlu-sive thrombosis of the arterio-venous conduit, during frac-tionated plasma separation and adsorption (FPSA) usingPrometheus in hemodialysis patients (2). Similar to theirfindings, we failed to detect overt thrombotic events inliver failure patients treated with the Prometheus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.